Urenco Limited’s head office is located in Stoke Poges, UK. Urenco’s subsidiary, Urenco Enrichment Company, responsible for sales, supply and logistics, is primarily based here along with other business functions.
Urenco Inc. and Urenco USA Inc., both Delaware registered companies, are based in Arlington, USA. Urenco Inc. markets our enrichment services and fuel cycle products and Urenco USA Inc. owns our US enrichment facility in New Mexico, Eunice.
Our German enrichment facility is located in Gronau. Its current production capacity is 3,700 tSW/a. Central Technology Group, responsible for enhancing the operation of Urenco’s centrifuge technology, is also based at Urenco Deutschland.Read more Urenco Deutschland
Our Dutch enrichment facility is located in Almelo. Its current production capacity is 5,100 tSW/a. Our stable isotopes business is also based at Urenco Nederland.Read more Urenco Nederland
Our UK enrichment facility is located in Capenhurst. Its current production capacity is 4,500 tSW/a. Our subsidiaries dedicated to overseeing our work in responsible nuclear stewardship are also based at our Capenhurst site.Read more Urenco UK
Our US enrichment facility is located in Eunice, New Mexico. It is the only commercial enrichment facility operating in the US, with a current production capacity of 4,600 tSW/a.Read more UUSA
Urenco ChemPlants operates our new Tails Management Facility in the UK, which deconverts the by-product of enrichment into a more stable form for long term storage for future enrichment or final disposal.Read more Urenco ChemPlants
Urenco Nuclear Stewardship Limited is responsible for the management of nuclear materials, decommissioning and recycling.Read more Urenco Nuclear Stewardship
Urenco Stable Isotopes draws on our expertise and capabilities in centrifuge technology to produce stable isotopes for medical, industrial and research applications.Read more Urenco Stable Isotopes